Latest News
News
Liver abnormalities, disease common in patients with psoriatic arthritis
Patients for whom monitoring of liver function tests is recommended include those with high body mass index, daily alcohol intake, high damaged...
News
Ankylosing spondylitis, axial PsA may be two different diseases
“Our study suggests that axial PsA and AS with psoriasis seem to be two different diseases with different genetics, demographics, and disease...
Conference Coverage
Psoriasis comorbidities: Biologics may help
SEATTLE – Better mental health, cardiovascular disease outcomes linked to treatment with biologics.
News
Obesity, moderate drinking linked to psoriatic arthritis
Reduction in body mass index over time also was associated with lower risk of developing psoriatic arthritis.
News
Long-term advantages may not endure after early tight control in psoriatic arthritis
Long-term follow-up data from the TICOPA study showed no significant difference in disease activity between tight control and standard care.
News
FDA finds increased blood clot, death risk associated with Xeljanz
The agency announced newly approved warnings and a new limitation on the approved indication for ulcerative colitis.
News
Hadlima approved as fourth adalimumab biosimilar in U.S.
Hadlima gets seven of Humira’s indications.
Conference Coverage
Secukinumab reduced joint pain of psoriatic arthritis in early data from phase 3b trial
MADRID – Secukinumab was superior to placebo for the primary endpoint of ASAS20 based on the initial 12-week data...
Conference Coverage
Novel topical psoriasis treatment targets nerve pathways
MILAN – The nonsteroidal investigative drug SNA-120 helped with psoriasis severity, burning, and pain.
Conference Coverage
Tildrakizumab shows positive effects in active psoriatic arthritis
MADRID – Already approved as a treatment for chronic plaque psoriasis, tildrakizumab (Ilumya) may also be beneficial in psoriatic arthritis,...